LifeMD Appoints Shayna Webb Dray as COO and Promotes Two Executives
PorAinvest
jueves, 31 de julio de 2025, 10:33 am ET1 min de lectura
LFMD--
Shayna Webb Dray, an accomplished operations and supply chain executive with over 15 years of experience, joined LifeMD in 2021 as the Head of Supply Chain and Procurement. She has been instrumental in the company's growth, most recently serving as Senior Vice President of Operations. In her new role as COO, Ms. Webb Dray will oversee the strategic direction of the Care Center, Pharmacy, Clinical Operations, and Project Management Office, as well as the successful launch, operationalization, and scaling of LifeMD's weight management program [1][2].
Jessica Friedeman, the current Chief Marketing Officer, has had her role expanded to include oversight of Product, making her the new Chief Marketing and Product Officer. Jacob Ellison, LifeMD's Vice President of Analytics, has been appointed Chief Analytics Officer, where he will oversee the organization's data strategy, AI innovation, and financial planning and analysis (FP&A) [3].
In a separate development, LifeMD has expanded its telehealth offerings in partnership with Novo Nordisk. The companies have collaborated to launch a discounted Wegovy bundle for self-pay patients prescribed Wegovy. The bundle, priced at $299, includes access to LifeMD's telehealth services and Novo Nordisk's Wegovy medication [1][3].
These strategic moves by LifeMD aim to enhance operational efficiency, expand product offerings, and improve patient access to affordable healthcare services. The company's focus on leveraging technology and data-driven insights positions it well to continue its growth trajectory in the virtual healthcare market.
References:
[1] https://www.marketscreener.com/news/lifemd-inc-appoints-shayna-webb-dray-as-chief-operating-officer-and-promotes-two-executives-ce7c5fdddc88f62d
[2] https://www.marketscreener.com/news/lifemd-appoints-shayna-webb-dray-as-coo-ce7c5fdddc8eff26
[3] https://www.globenewswire.com/news-release/2025/07/31/3124951/6480/en/LifeMD-Names-COO-and-Promotes-Two-Executives.html
NVO--
LifeMD has appointed Shayna Webb Dray as its new COO and promoted two executives. The company has also expanded its telehealth offerings with LifeMD and partnered with Novo Nordisk to launch a discounted Wegovy bundle for self-pay patients prescribed Wegovy.
LifeMD, Inc. (Nasdaq: LFMD) has appointed Shayna Webb Dray as its new Chief Operating Officer (COO) and promoted two executives, Jessica Friedeman and Jacob Ellison, to expanded roles. Additionally, the company has expanded its telehealth offerings and partnered with Novo Nordisk to launch a discounted Wegovy bundle for self-pay patients prescribed Wegovy.Shayna Webb Dray, an accomplished operations and supply chain executive with over 15 years of experience, joined LifeMD in 2021 as the Head of Supply Chain and Procurement. She has been instrumental in the company's growth, most recently serving as Senior Vice President of Operations. In her new role as COO, Ms. Webb Dray will oversee the strategic direction of the Care Center, Pharmacy, Clinical Operations, and Project Management Office, as well as the successful launch, operationalization, and scaling of LifeMD's weight management program [1][2].
Jessica Friedeman, the current Chief Marketing Officer, has had her role expanded to include oversight of Product, making her the new Chief Marketing and Product Officer. Jacob Ellison, LifeMD's Vice President of Analytics, has been appointed Chief Analytics Officer, where he will oversee the organization's data strategy, AI innovation, and financial planning and analysis (FP&A) [3].
In a separate development, LifeMD has expanded its telehealth offerings in partnership with Novo Nordisk. The companies have collaborated to launch a discounted Wegovy bundle for self-pay patients prescribed Wegovy. The bundle, priced at $299, includes access to LifeMD's telehealth services and Novo Nordisk's Wegovy medication [1][3].
These strategic moves by LifeMD aim to enhance operational efficiency, expand product offerings, and improve patient access to affordable healthcare services. The company's focus on leveraging technology and data-driven insights positions it well to continue its growth trajectory in the virtual healthcare market.
References:
[1] https://www.marketscreener.com/news/lifemd-inc-appoints-shayna-webb-dray-as-chief-operating-officer-and-promotes-two-executives-ce7c5fdddc88f62d
[2] https://www.marketscreener.com/news/lifemd-appoints-shayna-webb-dray-as-coo-ce7c5fdddc8eff26
[3] https://www.globenewswire.com/news-release/2025/07/31/3124951/6480/en/LifeMD-Names-COO-and-Promotes-Two-Executives.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios